Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Immunological Methods|July 13, 2010
A cell-free assay to estimate the neutralizing capacity of granulocyte-macrophage colony-stimulating factor autoantibodiesShinya Urano, Chinatsu Kaneko, Takahito Nei, et al.Immunology Letters|June 14, 2019
Memory B cell pool of autoimmune pulmonary alveolar proteinosis patients contains higher frequency of GM-CSF autoreactive B cells than healthy subjectsTakahito Nei, Shinya Urano, Natsuki Motoi, et al.Clinical Immunology (Orlando, Fla.)|November 12, 2013
Light chain (κ/λ) ratio of GM-CSF autoantibodies is associated with disease severity in autoimmune pulmonary alveolar proteinosisTakahito Nei, Shinya Urano, Yuko Itoh, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|February 28, 2012
IgM-type GM-CSF autoantibody is etiologically a bystander but associated with IgG-type autoantibody production in autoimmune pulmonary alveolar proteinosisTakahito Nei, Shinya Urano, Natsuki Motoi, et al.Journal of Medical Genetics|November 16, 2010
Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RBTakeshi Tanaka, Natsuki Motoi, Yoshiko Tsuchihashi, et al.American Journal of Respiratory and Critical Care Medicine|January 19, 2008
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in JapanYoshikazu Inoue, Bruce C Trapnell, Ryushi Tazawa, et al.Respiratory Medicine|November 25, 2011
Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosisKazumasa Ohashi, Atsuyasu Sato, Toshinori Takada, et al.American Journal of Respiratory and Critical Care Medicine|February 20, 2010
Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosisRyushi Tazawa, Bruce C Trapnell, Yoshikazu Inoue, et al.Pageof 1